298380.KQ
ABL Bio Inc.
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 67,600.00
−2.45%Margins
Gross margin
28.4%
EBITDA margin
-235.5%
EBIT margin
-251.2%
Net margin
-229.5%
FCF margin
-137.6%
-45.9%
Return on equity
-28.7%
Return on assets
-38.0%
Return on invested capital
0.12x
Asset turnover
-KRW 41.8B
Cash from operations
KRW 3.0K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026